“…These two drugs display several interesting parallels: both hamper fetal blood perfusion either directly (thalidomide) or indirectly (misoprostol); both produce systemic and especially ophthalmologic malformations, primarily coloboma and microphtalmos (Miller et al, 2004(Miller et al, , 2005; both frequently cause prenatally exposed children to develop signs of Moebius sequence, including horizontal strabismus (Duane syndrome) and facial nerve palsy due to the involvement of the VI and VII cranial nerves (Bandim et al, 2003;Miller et al, 2005); both are associated with enhanced risk of autism and/or mental retardation, provided exposure occurs early in development (Miller et al, 2005;Strömland et al, 1994). Patients with idiopathic Moebius sequence and with no history of prenatal exposure to thalidomide or misoprostol have been found at enhanced risk of autism by some (Gillberg and Steffenburg, 1989), but not by others (Briegel et al, 2009). The critical period for misoprostol has not been defined with the same precision, but it is known that maximum fetal vulnerability occurs during the first 2 months of pregnancy, and possible 5-6 weeks after fertilization (i.e., 7-8 weeks since the last menstrual cycle) (Bandim et al, 2003).…”